Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
Vaccine|May 14, 2025
Clinical and regulatory development strategies for GBS vaccines intended for maternal immunisation in low- and middle-income countriesKirsty Le Doare, Virginia Benassi, Marco Cavaleri, et al.
Bioanalysis|September 25, 2020
Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISAKatrina M Nolan, Yuhua Zhang, Joseph M Antonello, et al.
Human Vaccines & Immunotherapeutics|May 22, 2018
Predicting the impact of pneumococcal conjugate vaccine programme options in VietnamOlivier Le Polain De Waroux, W John Edmunds, Kensuke Takahashi, et al.
Plos One|October 3, 2013
Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypesLindsay R Grant, Sarah E O'Brien, Polly Burbidge, et al.
Vaccine|December 17, 2014
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation scheduleShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Infection and Immunity|August 17, 2002
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protectionMoya Burrage, Andrew Robinson, Ray Borrow, et al.
The Pediatric Infectious Disease Journal|December 17, 2013
Methods for a systematic review of pneumococcal conjugate vaccine dosing schedulesJennifer D Loo, Laura Conklin, Maria Deloria Knoll, et al.
Vaccine|July 29, 2014
Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: a randomized phase I clinical trialCarlos P Dotres, Rinaldo Puga, Yariset Ricardo, et al.
Msphere|June 21, 2019
Assignment of Serotype-Specific IgG1, IgG2, and IgA Weight-Based Antibody Units to the Human Pneumococcal Standard Reference Serum, 007spScott Jones, Kier Finnegan, Jae Hee Wee, et al.
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniaeSandra Romero-Steiner, Carl Frasch, Nelydia Concepcion, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Vaccine|May 14, 2025
Clinical and regulatory development strategies for GBS vaccines intended for maternal immunisation in low- and middle-income countriesKirsty Le Doare, Virginia Benassi, Marco Cavaleri, et al.
Bioanalysis|September 25, 2020
Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISAKatrina M Nolan, Yuhua Zhang, Joseph M Antonello, et al.
Human Vaccines & Immunotherapeutics|May 22, 2018
Predicting the impact of pneumococcal conjugate vaccine programme options in VietnamOlivier Le Polain De Waroux, W John Edmunds, Kensuke Takahashi, et al.
Plos One|October 3, 2013
Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypesLindsay R Grant, Sarah E O'Brien, Polly Burbidge, et al.
Vaccine|December 17, 2014
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation scheduleShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Infection and Immunity|August 17, 2002
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protectionMoya Burrage, Andrew Robinson, Ray Borrow, et al.
The Pediatric Infectious Disease Journal|December 17, 2013
Methods for a systematic review of pneumococcal conjugate vaccine dosing schedulesJennifer D Loo, Laura Conklin, Maria Deloria Knoll, et al.
Vaccine|July 29, 2014
Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: a randomized phase I clinical trialCarlos P Dotres, Rinaldo Puga, Yariset Ricardo, et al.
Msphere|June 21, 2019
Assignment of Serotype-Specific IgG1, IgG2, and IgA Weight-Based Antibody Units to the Human Pneumococcal Standard Reference Serum, 007spScott Jones, Kier Finnegan, Jae Hee Wee, et al.
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniaeSandra Romero-Steiner, Carl Frasch, Nelydia Concepcion, et al.
Pageof 25